Cohen Klingenstein’s Bristol-Myers Squibb BMY Stock Holding History

Cohen Klingenstein’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.97M	Hold	47,559	–	–	0.08%	102
2026 Q2	$2.74M	Hold	47,559	–	–	0.08%	104
2026 Q1	$2.88M	Hold	47,559	–	–	0.09%	97
2025 Q4	$2.57M	Hold	47,559	–	–	0.08%	105
2025 Q3	$2.14M	Hold	47,559	–	–	0.07%	112
2025 Q2	$2.2M	Hold	47,559	–	–	0.07%	113
2025 Q1	$2.9M	Hold	47,559	–	–	0.11%	91
2024 Q4	$2.69M	Sell	47,559 -21,000	-31%	-$1.17M	0.09%	96
2024 Q3	$3.55M	Sell	68,559 -841	-1%	-$39.5K	0.12%	96
2024 Q2	$2.88M	Hold	69,400	–	–	0.1%	101
2024 Q1	$3.76M	Hold	69,400	–	–	0.14%	93
2023 Q4	$3.56M	Hold	69,400	–	–	0.15%	92
2023 Q3	$4.03M	Hold	69,400	–	–	0.18%	82
2023 Q2	$4.44M	Hold	69,400	–	–	0.19%	79
2023 Q1	$4.81M	Hold	69,400	–	–	0.23%	74
2022 Q4	$4.99M	Hold	69,400	–	–	0.25%	71
2022 Q3	$4.93M	Hold	69,400	–	–	0.26%	68
2022 Q2	$5.34M	Hold	69,400	–	–	0.27%	66
2022 Q1	$5.07M	Hold	69,400	–	–	0.21%	77
2021 Q4	$4.33M	Sell	69,400 -13,654	-16%	-$801K	0.17%	90
2021 Q3	$4.91M	Sell	83,054 -12,062	-13%	-$794K	0.21%	79
2021 Q2	$6.36M	Hold	95,116	–	–	0.27%	66
2021 Q1	$6M	Hold	95,116	–	–	0.28%	68
2020 Q4	$5.9M	Hold	95,116	–	–	0.29%	66
2020 Q3	$5.74M	Hold	95,116	–	–	0.32%	66
2020 Q2	$5.59M	Hold	95,116	–	–	0.34%	65
2020 Q1	$5.3M	Hold	95,116	–	–	0.39%	59
2019 Q4	$6.1M	Buy	95,116 +50,116	+111%	+$2.87M	0.35%	66
2019 Q3	$2.28M	Buy	45,000 +21,000	+88%	+$987K	0.14%	116
2019 Q2	$1.09M	Buy	+24,000	New	+$1.12M	0.08%	145

Other funds holding BMY

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Cohen Klingenstein's BMY Position: Q3 2026 in Review

Cohen Klingenstein held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 47,559 shares worth $2.97M. The position accounts for 0.08% of the portfolio, ranked #102.

Cohen Klingenstein first reported a position in BMY in Q2 2019 and has held it in 30 quarters since. The position peaked at $6.36M in Q2 2021. 1,683 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Cohen Klingenstein held 47,559 shares of Bristol-Myers Squibb worth $2.97M as of Q3 2026.
Cohen Klingenstein left its Bristol-Myers Squibb share count unchanged in Q3 2026.
Bristol-Myers Squibb made up 0.08% of Cohen Klingenstein's portfolio in Q3 2026, its #102 holding.
Cohen Klingenstein first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 30 quarters since.
Cohen Klingenstein's Bristol-Myers Squibb position peaked at $6.36M in Q2 2021.
1,683 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Cohen Klingenstein's 13F filing for Q3 2026, filed 15 Oct 2026.